Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Valemetostat Tosylate with Drug Combination for Patients with Previously Treated Solid Tumors
ItalyStudy on Botulinum Toxin Type A for Adults with Chronic Pelvic Pain Syndrome (CPPS)
ItalyStudy on the Safety and Effectiveness of Metal Panel Allergens for Diagnosing Allergic Contact Dermatitis and Eczema in Patients
ItalyStudy of M9140 for Patients With Advanced Pancreatic Cancer
ItalyStudy on the Effectiveness of Tezepelumab for Adults with Eosinophilic Granulomatosis with Polyangiitis (EGPA)
ItalyStudy on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections
ItalyStudy of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)
ItalyStudy on the Effectiveness of Ixekizumab and Methotrexate for Treating Dactylitis in Patients with Psoriatic Arthritis
ItalyStudy on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis
ItalyStudy on Relugolix and Radiation Therapy for Patients with Intermediate Risk Prostate Cancer
ItalyStudy of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy
ItalyStudy on Reducing Post-Surgery Complications in Cancer Patients Using Ketorolac, Aspirin, and a Drug Combination
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
